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AbstrACt
Aim To describe how decision making inter-relates with 
the sequence of events in individuals who die during 
admission and identify situations where formal treatment 
escalation plans (TEPs) may have utility.
Design and methods A retrospective case note review 
using stratified sampling. Two data analysis methods were 
applied concurrently: directed content analysis and care 
management process mapping via annotated timelines 
for each case. Analysis was followed by expert clinician 
review (n=7), contributing to data interpretation.
sample 45 cases, age range 38–96 years, 23 females 
and 22 males. Length of admission ranged from <24 hours 
to 97 days.
results Process mapping led to a typology of care 
management, encompassing four trajectories: early 
de-escalation due to catastrophic event; treatment with 
curative intent throughout; treatment with curative intent 
until significant point; and early treatment limits set. 
Directed content analysis revealed a number of contextual 
issues influencing decision making. Three categories 
were identified: multiple clinician involvement, family 
involvement and lack of planning clarity; all framed by 
clinical complexity and uncertainty.
Conclusions The review highlighted the complex care 
management and related decision-making processes for 
individuals who face acute deterioration. These processes 
involved multiple clinicians, from numerous specialities, 
often within hierarchical teams. The review identified the 
need for visible and clear management plans, in spite 
of the frame of clinical uncertainty. Formal TEPs can be 
used to convey such a set of plans. Opportunities need 
to be created for patients and their families to request 
TEPs, in consultation with the clinicians who know them 
best, outside of the traumatic circumstances of acute 
deterioration.
bACkgrounD  
Clinical decision making in the context 
of acute deterioration during hospital 
admission is complex. Such decisions are 
frequently made in the face of uncertainty, 
characterised by: lack of underpinning 
information or diagnostic clarity, necessity 
for rapid decision making and the inability 
of patients to collaborate in discussions 
and decisions because of the acuity of their 
condition.1 
Previous research has focused on the 
illness trajectories of deteriorating patients 
or on clinical decision making in the specific 
context of critical care. The wider context 
of care management and related deci-
sion making remains an unresearched area. 
Murray et al2 highlighted the value of aware-
ness of illness trajectories as a mechanism for 
clinicians to help plan care to meet patients’ 
needs and for families to cope. More recently, 
Etkind and colleagues3 defined trajectories of 
final illness among patients who died while 
inpatients. These were defined a priori to 
strengths and limitations of this study
 ► There is a lack of description of escalation-related 
decision making in the context of deterioration out-
side of the critical care environment. Our study set-
ting was the comprehensive hospital environment 
and individuals who were facing acute deterioration 
that led to death.
 ► The study explored clinical decision-making pro-
cesses: the types and range of decisions made, the 
involvement of families in these processes and the 
interaction between clinical teams. Care manage-
ment trajectories provoked by acute deterioration 
were characterised via typology, including points of 
significance in the sequence of events. Contextual 
issues influencing decision making were described: 
multiple clinician involvement, family involvement 
and lack of planning clarity; all framed by clinical 
complexity and uncertainty.
 ► While the sample was stratified, it was small, select-
ed from a single acute hospital trust. However, two 
data analysis methods were applied concurrently 
(followed by expert clinician review): directed con-
tent analysis and care management process map-
ping via annotated timelines.
 ► Examination of decision-making processes high-
lighted areas for improvement and the potential 
impact of formal treatment escalation plans through 
pre-emptive decision  making and patient involve-
ment outside of crisis situations.
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their case note review as: predictable (gradual deteriora-
tion during admission); predictable (rapid deterioration 
during admissions); unpredictable course during hospital 
admission; and sudden death. One hundred and forty-
nine cases were examined (all deaths over 11 months on 
five inpatient wards where the AMBER care bundle was 
implemented) and characterised according to one of 
four trajectories.
Our study progresses the above, which focused exclu-
sively on illness trajectories by expanding the focus to 
care management and understanding of the associated 
decision-making processes to inform clinical practice. 
Higginson and colleagues4 explored this area by exam-
ining patterns of decision making, but their work was 
specific to critical care. Only 16 cases were examined (in 
combination with interviews and non-participant obser-
vation), and four trajectories with different patterns of 
clinical decision making were identified: curative care 
from admission (to critical care); oscillating curative and 
comfort care; shift to comfort care; and comfort care 
from admission. They emphasised that ‘conflict’ in deci-
sion making could occur between relatives and staff and 
between and within clinical teams.
Given the complexity of clinical decision making related 
to acuity and deterioration, and perhaps the likelihood 
for ‘conflict’,4 there has been a move nationally and inter-
nationally to develop and implement formal treatment 
escalation plans (TEPs). Structured, procedure-specific 
TEPs are proposed as a mechanism by which to improve 
understanding and communication when escalation-re-
lated decisions need to be made and acted on.5 They 
provide a framework on which to base a conversation and 
document treatment options that are appropriate if a 
patient were to become acutely unwell. They vary in both 
design and use.5–7 Notable examples include: Universal 
Form of Treatment Options,8 Deciding Right (http://
www. nescn. nhs. uk/ common- themes/ deciding- right/) 
and Physician Orders for Life Sustaining Treatment.9 In 
the UK, there is growing interest in the national initia-
tive, instigated in 2014, led by the Resuscitation Council 
and the Royal College of Nursing, which generated the 
Recommended Summary Plan for Emergency Care and 
Treatment (http://www. respectprocess. org. uk/).
Despite this increasing awareness, little work has exam-
ined the implementation of TEPs. This study is part of a 
wider programme of work to inform the implementation 
and evaluation of TEPs as part of the Complexity, Patient 
Experience and Organisational Behaviour theme of the 
National Institute for Health Research Collaboration for 
Applied Health Research and Care Wessex. Additionally, 
the team has undertaken a review of communication and 
decision-making interventions directed at goals of care 
via a theory-led scoping review.10
Aims/objeCtives
The study explored the care management of those 
who deteriorate and die during hospital admission, 
characterising the resources mobilised, in as much detail 
as could be tracked through recourse to case notes. The 
aims were: to describe how decision-making processes 
inter-relate with the sequence of events for individuals 
who die during inpatient admission and to identify situ-
ations where treatment escalation plans may have had 
utility.
The objectives were:
1. To identify and characterise, via the generation of a 
typology, the care management trajectories of hospital 
inpatients facing acute pathophysiological deteriora-
tion that ultimately leads to death.
2. To map clinical decision-making processes, including 
the involvement of patients and families in decisions, 
identifying what leads to and triggers changes in man-
agement.
3. To identify the potential role of treatment escalation 
plans in providing a framework to support discussions 
and recording of decisions.
methoDology AnD methoDs
study design
A retrospective case note review exploring the care 
management of those who die during hospital admission.
sampling strategy
The case note review followed an initial audit of death 
certificate review forms (DCRFs) from all deaths at a 
single acute hospital trust in England (n=911) within 
a 6-month period (January–July 2015). Case notes of 
a 5% sample (45 sets of notes) of patients, aged over 
18 years were reviewed. The DCRF data enabled stratified 
sampling, ensuring appropriate representation across 
groups. Thirty-two mutually exclusive strata were created 
based on whether cases had all possible combinations of 
the following: do not attempt cardiopulmonary resus-
citation (DNACPR), palliative care team involvement, 
intensive care/high dependency management, evidence 
of escalation/de-escalation decision and unpredictable 
illness trajectory.3 Proportionate allocation was used to 
sample the same fraction from each strata, with a check 
that the total sample size was calculated as expected (ie, 
not affected by rounding of the numbers for each strata 
to integers).
Data collection
Data were collected from case notes only. Data collection 
tracked the period from admission to hospital through 
to each patient’s death to identify: (1) when decisions 
to escalate or de-escalate treatment were made, (2) how 
those decisions were made and (3) who was involved in 
these decisions. For those with a prolonged admission 
(>30 days), data collection was limited to the last 30 
days of admission (but included social and clinical data 
regarding their admission). The following data were 
extracted:
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 ► Clinical and demographic information regarding 
admission to hospital, including but not limited to, 
comorbidities and admitting specialism.
 ► End-of-life care (EOLC) and DNACPR informa-
tion, including but not limited to, whether CPR was 
attempted.
 ► Nature of any events leading to a discussion or deci-
sion regarding levels of care, who recognised and 
responded to the event, actions taken, further detail 
on escalation or de-escalation of care and outcomes 
from this. Here, ‘event’ referred to episodes such as 
clinical deterioration, ward rounds, specialist review 
or emergence of new clinical findings.
 ► How decisions were documented, including clarity of 
documentation and use of care plans.
 ► Evidence of patient and/or family involvement in 
decision making and how patient preferences and 
those of others are taken into account, including 
whether patient wishes were known in advance.
 ► Ward movements.
 ► Date and cause of death.
Data extraction was undertaken by two clinically quali-
fied researchers (NC and AC) and data recorded using an 
Excel spreadsheet pro forma (see online supplementary 
file 1). The pro forma was piloted on a set of notes and 
based on this changes to the form were made to facilitate 
usability and increase reliability of data extraction. This 
resulted in: inclusion of all causes of death (not just cause 
1a but also underlying causes 1b and 1c), and enabling of 
free-text entry for avoidable EOLC admission and failed 
EOLC discharge. The revised pro forma was tested by NC 
and AC on an initial sample of case notes (n=8) to assess 
utility and consistency of data entry. No further changes 
were required. At the end of data collection, a process 
of cross-checking by both researchers helped to mitigate 
against errors, ensure accuracy and consistency.
Data analysis
Two methods of data analysis were applied concurrently. 
First, case notes were treated as qualitative data and anal-
ysed using directed content analysis.11 The data within the 
pro forma were analysed using this method and directed 
towards: the event leading to the decision or discussion 
and the action taken and resulting outcomes and details 
regarding involvement and discussion with the patient 
and family. Data comprised verbatim transcription of 
relevant entries in the case notes to the pro forma. Addi-
tionally, field notes were analysed to capture limitations of 
case notes as a data source and recurrent issues (sequence 
of events and triggers for decision making) across cases.
Second, care management process mapping via anno-
tated timelines involving key events were developed for 
each case.12 These timelines included: escalation and 
de-escalation related decisions; involvement of patient 
and family in decision-making; clinical treatment plans 
made; investigations undertaken and treatment received; 
and key clinical information to inform probability of 
outcomes and prompt decisions.
Timelines were drawn for each case (NC and AC) and 
then grouped independently by NC and AC (double 
screened) into one of four care management trajectories, 
which became apparent during analysis. Categorisation of 
cases by the researchers were compared, with input from 
two additional clinical members of the research team (SL 
and AR). Where there was initial disagreement, the pro 
formas were revisited in a team discussion to agree final 
categorisation (n=11).
Diagrams were subsequently drawn to represent the 
group experience of the four care management trajecto-
ries. These were iteratively refined (NC, AC, SL and AR). 
They were combined with tabulated data representing 
the cases within each trajectory and a case exemplar (case 
study) and sent to a group of expert clinicians (repre-
senting a wide range of specialities) for review. They were 
asked to consider:
 ► Do the four care management trajectories capture 
the sequence of events and decision-making processes 
involved?
 ► Do the trajectories apply to patients you have seen 
recently who have then gone on to die while in 
hospital? Could you consider how they do or do not 
apply?
 ► Do these data demonstrate potential triggers for deci-
sion making or treatment escalation planning that 
you would like to see put into practice?
 ► Is there anything in the data you are surprised by or 
any other comments you would like to make?
Out of 13 experts approached, seven commented in 
detail on the data either face-to-face or via telephone/
email. Their feedback verified: the care management 
trajectories reflected what clinicians encounter in prac-
tice and were described in a way they could identify with; 
the classification of cases to the trajectories; and the 
authenticity of the case exemplars. They contributed to 
the overall interpretation of data.
ethical and research governance considerations
As access to patient identifiable data (case notes) was 
required without consent, support under section 251 of 
the National Health Service Act (2006) was sought and 
obtained via the Health Research Authority's Confidenti-
ality Advisory Group.13
Patient and public involvement (PPi)
A PPI champion worked closely with the research team 
on this study, and the wider programme, informing all 
study processes. Involvement led to the recommendation 
that the team solely access paper-based notes (to restrict 
the amount of data accessed) and not electronic medical 
records as originally planned.
results
sample characteristics
The age range of patients included (in the review of the 
45 sets of notes) was 38–96 years, with 23 female and 22 
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male. The length of admission ranged from <24 hours to 
97 days. Thirty-five patients had a DNACPR in place at 
time of death. Fifteen patients had palliative care team 
involvement.
A typology of care management
Analysis via process mapping led to the development of a 
typology of care management, encompassing four distinct 
trajectories. The trajectories characterised the sequence 
of events and decision-making processes through acute 
pathophysiological deterioration leading to death. They 
were:
1. Early de-escalation (within 24–48 hours of admission) 
due to catastrophic event — clinically observable signs 
and symptoms ± observable on imaging.
2. Treatment with curative intent throughout (no de-es-
calation) ± cardiopulmonary resuscitation.
3. Treatment with curative intent until significant point.
4. Early treatment limits set (within 48 hours of 
admission).
Table 1 displays the key characteristics of the cases 
represented by each trajectory. Each care management 
trajectory is described in sequence below, including a 
diagrammatic representation of the respective trajectory. 
Exemplar case studies for each trajectory are included 
in online supplementary file 2. The process of reviewing 
the data with expert clinicians added a valuable dimen-
sion to data interpretation. The depth and range of their 
feedback, via their experiential knowledge, is summarised 
in online supplementary file 3.
Early de-escalation due to catastrophic event
This trajectory was characterised by hospital admission 
due to ‘catastrophic’ events (figure 1). The event had 
occurred outside of hospital, was evident at the point 
of admission and referenced individuals who were in 
danger of dying on admission (eg, patients who were 
moribund secondary to shock) or those admitted with 
severe, critical illnesses (eg, major cerebrovascular 
accidents).
Following admission, there was a period of initial esca-
lation, with accompanying imaging, diagnostic investi-
gations such as blood tests or ECGs and treatment with 
intravenous antibiotics or fluids. This escalation also 
encompassed senior or specialist (eg, surgical and inten-
sive care) review.
A key feature of this trajectory was the early (within 
24–48 hours) recognition of an unsurvivable or irrevers-
ible event. All cases had at least one factor that identified 
this including: imaging results, clinically observable diag-
noses, reduced level of consciousness and/or consultant 
review. Following recognition of futility, discussions with 
family and next of kin preceded palliation in all cases bar 
one. In this case, deterioration and death were so rapid 
as to prevent timely palliation. This trajectory was gener-
ally defined by short admissions, on average, patients died 
within 3 days.
Treatment with curative intent throughout
Trajectory 2 was characterised by treatment with curative 
intent for the duration of hospital admission (figure 2). 
Individuals were admitted with a variety of diagnoses, and 
admissions were characterised by ongoing care at ward or 
high dependency unit/intensive care unit (HDU/ICU) 
level for multiple issues. These included fluid balance 
management associated with cardiorenal failure or acute 
kidney injury, treatment of infections and management 
of ischaemic or arrhythmic cardiac disease.
This trajectory was also characterised by the develop-
ment of new diagnoses (eg, sepsis) or sudden, unpredict-
able events (eg, pulmonary embolism), which ultimately 
led to death. However, in these cases, such events did not 
trigger de-escalation (as in trajectory 3); patients were 
actively treated until death. In five of the eight cases, 
unsuccessful cardiopulmonary resuscitation occurred 
prior to death. In the three remaining individuals, 
DNACPR orders had been stimulated by senior clinician 
reviews and/or family discussions.
The reasons underlying a lack of de-escalation related 
to patient characteristics, individual preferences and the 
delivery or focus of healthcare. Some individuals were 
younger or normally fit and well with minimal comorbid-
ities, while others expressed a preference for active treat-
ment. For some, a recent intervention with curative intent, 
or the fact that they were awaiting discharge or transfer 
to alternative settings, meant that de-escalation was not 
a consideration. In others, the involvement of multiple 
specialist teams meant that the leading specialism (and 
thus the team who might be expected to make de-escala-
tion decisions) was not clear.
Treatment with curative intent until significant point
Trajectory 3 was characterised by curative intent treat-
ment until a significant point, triggering de-escalation 
of care (figure 3). These triggers included significant 
deterioration in the patient’s current condition (in the 
absence of a new diagnosis), for example, a reduction 
in consciousness level or patient agitation/distress, and 
new diagnoses (eg, infection or malignancy), which led 
to deterioration in the patient’s condition. A third trigger 
involved a new clinical specialism or out-of-hours review 
recognising poor prognosis and the futility of current 
treatment, prompting de-escalation.
All triggers for de-escalation prompted discussions with 
next of kin, family and the patient or other clinical teams 
(if under shared-care management). Following these 
discussions, multistaged de-escalation ensued. The first 
stage involved the setting of ceilings of care and DNACPR 
orders. This first stage at times occurred prior to family 
discussion, but such discussion always preceded the 
second stage, which included stopping vital sign observa-
tions, early-warning activation scores and invasive inves-
tigations/treatments. In some cases, a time and intensity 
limited trial of treatment (eg, antibiotics) preceded a third 
stage of de-escalation, palliation. For patients receiving 
HDU/ICU level care, the latter stages of de-escalation 
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Table 1 Key characteristics of cases within the trajectories
Trajectory 1 cases (n=10) Trajectory 2 cases (n=8)
Age (median, range) 79.5 (47–94) years Age (median, range) 83 (53–96) years
Gender 6 female; 4 male Gender 1 female; 7 male
CACI* Comorbidity Score 
(median, range)
5.5 (4–10) CACI Comorbidity Score 
(median, range)
6.5 (2–9)
Social history Care/nursing home 
resident or respite
2 Social history Care/nursing home 
resident or respite
1
Home carers 1 Home carers 2
Length of admission 
(median, range)
3 (1–16†) days Length of admission (median, 
range)
7.5 (2–19) days
Primary reason for 
admission
Cerebrovascular accident 3 Primary reason for 
admission
Respiratory (infective) 3
Gastrointestinal 2 Ischaemic/arrhythmic 
cardiac disease
2
Sepsis 3 Fall 1
Ischaemic cardiac disease 1 Fracture 1
Peripheral vascular 
disease
1 Cellulitis 1
Triggers for recognition 
of irreversibility/
unsurvivable event
Some cases has more than 
one trigger*
Imaging results 3 Ongoing care management/
treatment issues
All cases had multiple 
issues* 
Fluid balance (cardiorenal 
failure)
4
Clinically observable 
diagnosis
4 Acute (on chronic) kidney 
injury
2
Consultant review 1 Ischaemic/arrhythmic 
cardiac disease
5
Reduced consciousness 3 Respiratory tract infection 8
Urinary tract infection 1
Diabetic control 2
Pulmonary embolism 1
Respiratory failure 4
Received CCO/ITU‡ review 1 Received CCO/ITU review 1
Received HDU/ITU§ care Intensive care unit 1 Received HDU/ITU care HDU 1
ICU 1
CPR¶ attempted and 
unsuccessful
5
Reasons for no de-escalation
Some cases had more 
than one reason*
Awaiting transfer/discharge 3
Patient preference/limited 
or no family involvement
2
Young/normally fit and 
well/few comorbidities
3
Post (curative intent) 
intervention
1
Input from multiple 
specialist teams
2
Trajectory 3 cases (n=18) Trajectory 4 cases (n=9)
Age (median, range) 80.5 (38-88) years Age (median, 
range)
86 (63–91) years
Gender 12 female; 6 male Gender 4 female; 5 male
CACI Comorbidity Score
(median, range)
6 (1-12) CACI Comorbidity Score
(median, range)
8 (5–14)
Social history Care/nursing home
resident or respite
1 Social history Care/nursing home 
resident or respite
5
Continued
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involved the withdrawal of treatment. There was usually 
some degree of treatment provided in parallel to multi-
staged de-escalation, although this was limited, typically 
involving antibiotics and intravenous fluids. The time 
between the significant point, which triggered de-escala-
tion and patient death, was between 0–10 days; however, 
this trajectory was characterised by the longest and most 
varied admission length, 3–97 days.
Early treatment limits set
Trajectory 4 was characterised by the presence of early 
treatment limits, set within 48 hours of admission 
Trajectory 3 cases (n=18) Trajectory 4 cases (n=9)
Home carers 4 Home carers 1
Length of admission
(median, range)
17.5 (3-97) days Length of admission
(median, range)
12 (2–28) days
Primary reason for 
admission
Gastrointestinal 3 Primary reason for 
admission
Sepsis 3
Cerebrovascular accident 2 Respiratory tract infection 2
Respiratory tract infection 5 Malignancy 1
Urinary tract infection 1 Cerebrovascular accident 1
Specialist treatment
(chemotherapy, cardio 
ablation)
2 Fall 1
Haematological 1 Acute heart failure 1
Fracture 1
General decline + 
hypertension
2
Respiratory 1
Received CCO/ITU review 4 Pre-existing factors for 
characterising admission
Some cases had more than 
one factor*
Frailty 5
History of recent 
deterioration
2
Pre-existing DNACPR** 4
Current malignancy 3
Underlying dementia 3
Already known to palliative 
care
3
Received HDU/ITU care Intensive care unit 3 Prompts for setting early 
treatment limits
Some cases had more 
than one prompt*
Senior clinician review 7
Patient’s prior wishes 
expressed by family
4
Discussion with patient 3
Marked deterioration 4
Significant point triggering 
de-escalation
Some cases has more than 
one more trigger*
Significant deterioration
in current condition
6
New diagnosis leading
to deterioration in 
condition
11 
New clinical team/out of 
hours input
recognising
poor prognosis
4 
*Charlson Age Comorbidity Index (CACI; www.pmidcalc.org/7722560) (Charlson et al20).
†One individual lived for 16 days despite catastrophic event due to younger age.
‡Critical care outreach/intensive care review.
§High dependency/intensive care.
¶Cardiopulmonary resuscitation.
**Do not attempt cardiopulmonary resuscitation.
HDU, high dependency unit; ICU, intensive care unit. 
Table 1 Continued 
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(figure 4). The triggers for setting limits included patient 
refusal of treatment, discussions with family, senior clini-
cian review and marked deterioration in the patients’ 
condition. Crucially, these triggers occurred against 
backgrounds of: history of recent deterioration, frailty, 
underlying diagnoses of dementia or malignancy and 
the presence of pre-existing DNACPR orders and palli-
ative care involvement. In line with this, the patients in 
this trajectory had the highest average comorbidity scores 
and ages.
Early treatment limits formed the start of a multistaged 
de-escalation process, which occurred across the dura-
tion of admission. This de-escalation started with treat-
ment limits (DNACPR, not for intubation/dialysis/ICU 
care and ward-based care) before progressing to more 
active de-escalation (ceasing early warning scores, ceasing 
antibiotics/intravenous fluids/regular medications, palli-
ation and commencement of an individualised end of life 
care plan).
Key to this trajectory was the level of ongoing treatment 
in parallel with the staged de-escalation. Despite early 
treatment limits being set, ongoing treatment involved 
a far more extensive range of treatment (interventions, 
therapy and medications) than in trajectory 3. Interven-
tions included catheterisation, nasogastric tubes and 
blood transfusions. There was therapy input from physio-
therapists, speech and language therapists, dietitians and 
occupational therapy teams, and medications included 
diuretics and antibiotics. Nonetheless, ongoing treatment 
was restricted to a ward environment as clinical history 
meant these individuals were not candidates for intensive 
treatment.
the categories
In addition to the care management typology, our 
directed content analysis revealed a number of contex-
tual issues, which influenced decision making. We iden-
tified three interlinked categories consisting of: multiple 
clinician involvement, family involvement and lack of 
planning clarity. The categories were framed by clinical 
complexity and uncertainty.
Clinical complexity and uncertainty
The cases demonstrated clinical complexity caused in 
the main by multiple comorbidities, new diagnoses or 
Figure 1 Early de-escalation due to catastrophic event.
Figure 2 Treatment with curative intent throughout.
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undiagnosed conditions and challenging management, 
for example, of sepsis, kidney injury and frailty. Chal-
lenging management of fluid balance issues associated 
with multiple concurrent comorbidities, and the onset 
of new infections, were a frequent occurrence. A lack of 
clarity surrounding definitive diagnoses often meant that 
clinicians were ‘working in the dark’ trying to maximise 
management despite ongoing uncertainty. Although 
there were some more clearly defined diagnoses and 
management paths evidenced (such as stroke), with 
greater clinical predictability, these cases were in the 
minority.
Decision making was complicated by frequently 
changing clinical situations, particularly in relation to 
new findings or diagnoses. Escalation-related decisions 
were required that could adapt to these changing situ-
ations, where previous management plans were rapidly 
rendered inappropriate.
multiple clinician involvement
Clinical management via multiple specialities, therapy 
and outreach teams could preclude sight of the patient’s 
prognosis. This was evidenced by treatment decisions and 
therapy involvement that did not always reflect an indi-
vidual’s prognosis. Likewise, the practicalities of input 
from multiple specialisms, including numerous repeat 
reviews and interplay between different teams, often 
acted to elongate decision-making processes, and added 
complexity when no-one team took responsibility for 
leading decisions.
There was evidence of a hierarchy in decision making, 
with senior clinicians most often instigating decisions. 
Junior doctors were less likely to make escalation-related 
decisions, especially concerning placing limitations on, 
or removal of, treatments. Junior doctors, when required 
to make decisions alone (particularly those working out 
of hours), were more likely to continue treatment escala-
tion, especially in the absence of prespecified escalation 
plans. As such, there was a clear role for senior review, 
with registrars and consultants instigating the majority of 
decisions regarding treatment limits and withdrawal of 
treatment.
The transfer of patients between wards and clinical 
teams added complexity to decision processes. There 
was evidence of transfers resulting in de-escalation plans 
being overlooked; however, in other circumstances, ward 
or team moves prompted new reviews and the initiation 
of appropriate planning. The positive influence of new 
perspectives or ‘fresh eyes’ on escalation-related deci-
sion making was apparent, especially via out-of-hours 
clinicians. It appeared that individuals not caught up 
Figure 4 Early treatment limits set.
Figure 3 Treatment with curative intent until significant point.
 o
n
 18 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022021 on 17 August 2018. Downloaded from 
9Campling N, et al. BMJ Open 2018;8:e022021. doi:10.1136/bmjopen-2018-022021
Open access
in the day-to-day management of patient care were able 
to see the ‘bigger picture’ regarding care management, 
often initiating ceilings of care, or prompting escalation 
plans.
Family involvement
The role and influence of the family was often central 
in the decision-making process. It was apparent that 
escalation-related decisions (ie, whether to continue to 
increase the intensiveness of treatment, for example, 
dialysis, intubation and ventilation or maintain treat-
ment at ward level) were often established and actioned 
before discussions with the family took place, whereas, 
de-escalation-related decisions (such as ceasing treat-
ments and commencing palliation) were postponed until 
after discussions with family. Family involvement and 
consensus agreement always preceded the withdrawal 
of treatment (eg, organ support and ventilation). This 
reflects the moral imperative to discuss such decisions 
with family. Additionally, family were involved in the deci-
sion-making process for DNACPR orders where there 
was any concern about patient competency. Families also 
played an important role in providing collateral histories 
for clinicians, enabling decision making to be placed in 
the context of an individual’s recent health. This was 
particularly the case with older patients where families 
could highlight weeks or months of recent deterioration 
or recurrent infections, aiding the admission clerking, 
and facilitating early treatment limits being set (trajectory 
4).
The impact of the familial role was most apparent 
when absent. In a few cases, where patients had limited 
or no family involvement, or lacked the physical pres-
ence of family members to prompt discussions, de-es-
calation decisions were not made (those in trajectory 
2). In contrast, where families were engaged, they were 
frequently involved in consultative decision making with 
clinical teams. These families were often able to provide 
clear instructions to clinicians because of their knowl-
edge of patients’ prior wishes. For example, relatives were 
recorded as stating that the ‘patient wouldn’t want to live like 
this’ and were therefore more likely to endorse clinician 
recommendations for treatment withdrawal. Addition-
ally, families often agreed with recommendations that if 
the patient did not respond to treatment, then a move to 
focus on palliation should occur. The converse did apply, 
although only in a few cases, whereby families stated that 
the patient would ‘want all done’. In situations where 
families were unsure of the patient’s wishes, further team 
meetings with the family were always undertaken.
lack of planning clarity
The data revealed a general lack of clarity and visibility 
regarding management plans in the case notes. However, 
the clinical complexity of these cases at times precluded 
the making of escalation-related plans or led to them being 
held in a type of uncommitted management ‘status’ until 
certainty was gained. Even where cogent management 
plans were made, they may not have been followed 
because there were no effective methods for signposting 
clinicians to plans buried in subsequent pages of notes. 
In addition, where management plans involved clear 
de-escalation, these were not always followed. This was 
sometimes more than just due to the lack of visibility in 
the notes and also due to clinical complexity and unpre-
dictability of deterioration, with fluctuations leading to 
patients temporarily improving or stabilising.
Initial clerking and history taking was paramount to 
the quality of decision making throughout admission. 
This was particularly apparent where clerking histories 
appeared ‘lost’, with key factors not carrying through into 
decisions made. Where an important comorbidity was not 
acknowledged during the admission clerking, this could 
continue to influence care over the length of admission.
DisCussion
This case note review and qualitative analysis, identi-
fied four care management trajectories, defining and 
mapping clinical decision-making processes in the 
context of acute pathophysiological deterioration. All 
trajectories from admission through to death were framed 
by clinical complexity and related uncertainty. In general, 
such complexity confounded decision-making processes. 
Nonetheless, in a minority of profoundly complex cases 
(eg, older age, associated frailty and comorbid and 
premorbid statuses), complexity could encourage esca-
lation-related decision making. This was apparent in the 
fourth trajectory, where early treatment limits were set 
based on patients’ preadmission morbidity. This concurs 
with Fritz et al14 who in a retrospective case note review 
found a lower threshold for completing DNACPR orders 
in patients with multiple co-morbidities.
The trajectories identified here expand those previ-
ously described by Higginson et al, which were exclusive 
to critical care, as they are applicable to hospital inpa-
tients irrespective of care setting.4 Consequently, our 
trajectories highlight: (a) significant points in care trajec-
tories where senior secondary review and re-evaluation of 
management plans would be valuable and (b) groups of 
patients for whom a formal TEP would be of particular 
benefit, as a framework to support discussions and the 
recording of decisions.
Our findings display significant points in care manage-
ment trajectories (1 and 3). These included the recogni-
tion of irreversibility, deterioration in current condition, 
new diagnoses leading to deterioration and new clinical 
or out-of-hours team involvement. It was these points that 
triggered discussions around escalation and ultimately 
decision making. We propose that while acting as trig-
gers, these points in trajectory 3 cases also present missed 
opportunities, for earlier, timely decision making. It was 
frequent for deterioration to occur out of hours, with 
important decisions left to on-call teams and sometimes 
more junior clinicians. As previous studies have shown, 
this can preclude decisions that reflect the best interests 
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and preferences of the patient.12 Here, clear manage-
ment plans are required that pre-empt the possibility of 
deterioration and outline the patients’ wishes in such 
circumstances, as well as realistic parameters of care.
The absence of significant points in some cases by which 
to trigger decision making, such as those in trajectory 2, 
leads to a proposition made by the study’s expert clinical 
reviewers that strategic senior reviews are required. It is 
possible that earlier senior review secondary to a postad-
mission review may enable appropriate re-evaluation and 
alter management plans. Nevertheless, a lack of recogni-
tion of the dying phase, even by senior clinicians, high-
lighted the role and contribution of palliative care teams 
in questioning ongoing investigations or treatment and 
stimulating appropriate symptom control.
It is known that formal TEPs are helpful in stimu-
lating discussions, formulating clear plans, ensuring 
patient preferences are considered5 15 and perceived as 
a good idea by patients, families and healthcare profes-
sionals.5 15–17 In addition, they help healthcare profes-
sionals structure their discussions with patients and 
families, and record their decisions, improving docu-
mentation clarity18 and escalation-related communica-
tion within clinical teams.16 19 Despite this, in the case 
notes reviewed, there were no recorded instances of a 
formal TEP being used to aid decision making. Four 
patients held pre-existing DNACPR orders, but none had 
evidence of an advance care plan or formal TEP. Despite 
the small number of pre-existing DNACPR orders in 
the review, their existence led clinicians to have wider 
escalation-related discussions with patients and families. 
There is also a pragmatic argument that documenting 
a DNACPR decision should trigger consideration of a 
TEP, as a logical continuation of the resuscitation discus-
sion. However, based on our care trajectories, treatment 
escalation decision making must account for premorbid 
status, which may, if possible, be best assessed outside 
of crisis situations and acute deterioration. To incorpo-
rate patient preferences, completion of formal TEPs in 
primary care would enable patients who might be too 
acutely unwell on admission to hospital to participate 
in such discussions (of particular relevance to trajec-
tories 1 and 4). Although it is impossible to anticipate 
the catastrophic events that occurred for individuals in 
trajectory 1, it is contended that those individuals who 
have significant comorbidities and resulting premorbid 
dependencies (such as those in trajectory 4) should be 
party to sensitive discussion and documentation of a TEP 
in primary and community care settings.
In summary, this review has highlighted a number of 
clinically relevant findings, with resulting recommenda-
tions, which the authors contend might represent best 
practice:
 ► Accurate history taking surrounding premorbid func-
tional status, comorbidity and level of dependency is 
vital for establishing ceilings of care.
 ► Regular senior clinician involvement results in 
ongoing review of prognosis and facilitates effective 
decision making in complex patients where there is 
significant clinical uncertainty.
 ► Awareness of a patient’s premorbid wishes and, where 
possible, discussion with the patient, should be a 
priority in deciding ceilings of care.
 ► Discussion with family around prognosis should 
complement discussions with the patient.
 ► ‘Fresh eyes’ are a valuable tool for reassessing 
patients’ prognosis and should be used more widely 
for complex patients with significant clinical uncer-
tainty, not responding to treatment.
 ► A senior clinician with overall responsibility for the 
patient should facilitate multidisciplinary discussion 
of patients with multiple team involvement.
 ► Earlier involvement of palliative care specialists in 
patient assessment would aid decision making and 
recognition of those who are at the end of life.
 ► Formal TEPs do not preclude active management of 
reversible conditions but would aid decision making 
and need to be introduced and adopted by clinical 
teams.
 ► Patients with TEPs need these to be readily visible 
to teams providing ongoing care to ensure they are 
followed.
ConClusion
This review highlighted the complex care management 
and related decision-making processes of individuals who 
face acute pathophysiological deterioration leading to 
death in hospital. Such decision-making processes involve 
multiple layers of clinicians, from numerous specialities, 
within often hierarchical teams. Families were involved in 
contributing to decision making; in these circumstances, 
patients themselves were frequently too acutely unwell 
to contribute to all stages of the process. The review 
identified the need for visibility and clarity of manage-
ment plans, in spite of the surrounding frame of clinical 
uncertainty. Even where clear plans were documented 
they could be buried by subsequent pages of notes, with 
no effective signposting, a particular problem when 
further deterioration occurred out of hours. Therefore, 
the review suggests that there is a clear role for formal 
TEPs to be introduced more widely into routine practice. 
Opportunities need to be created for patients and their 
families to be able to ask for such plans to be made, in 
consultation with clinicians who know them best, outside 
of the circumstances of acute deterioration.
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